Milestone Scientific Inc. (MLSS) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $0.44 (+2.66%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
MLSS vs Sector & Market
| Metric | MLSS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +129.6% | +22243.6% | +21.5% |
| P/E Ratio | -4.67 | 3.77 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $10M | $10M | $10M | 2 |
| 2027-12-31 | $10M | $10M | $11M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.06 | $-0.06 | $-0.06 | 2 |
| 2027-12-31 | $-0.06 | $-0.06 | $-0.06 | 1 |
Frequently Asked Questions
What is the analyst consensus for MLSS?
The consensus among 1 analysts covering Milestone Scientific Inc. (MLSS) is Buy with an average price target of $1.00.
What is the highest price target for MLSS?
The highest analyst price target for MLSS is $1.00.
What is the lowest price target for MLSS?
The lowest analyst price target for MLSS is $1.00.
How many analysts cover MLSS?
1 analysts have issued ratings for Milestone Scientific Inc. in the past 12 months.
Is MLSS a buy or sell right now?
Based on 1 analyst ratings, MLSS has a consensus rating of Buy (2.00/5) with a +129.6% upside to the consensus target of $1.00.
What are the earnings estimates for MLSS?
Analysts estimate MLSS will report EPS of $-0.06 for the period ending 2026-12-31, with revenue estimated at $10M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.